0001104659-23-079110.txt : 20230707 0001104659-23-079110.hdr.sgml : 20230707 20230707160600 ACCESSION NUMBER: 0001104659-23-079110 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230424 FILED AS OF DATE: 20230707 DATE AS OF CHANGE: 20230707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Litchman Manuel MD CENTRAL INDEX KEY: 0001709485 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38191 FILM NUMBER: 231076829 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MUSTANG BIO, INC. CENTRAL INDEX KEY: 0001680048 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473828760 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 377 PLANTATION STREET CITY: WORCESTER STATE: MA ZIP: 01605 BUSINESS PHONE: 7816524500 MAIL ADDRESS: STREET 1: 377 PLANTATION STREET CITY: WORCESTER STATE: MA ZIP: 01605 4 1 tm2320790-1_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-04-24 0 0001680048 MUSTANG BIO, INC. MBIO 0001709485 Litchman Manuel MD 377 PLANTATION STREET WORCESTER MA 01605 1 1 0 0 President and CEO 0 COMMON STOCK, PAR VALUE $0.0001 2023-04-24 4 A 0 5000 0.000 A 111079 D Represents an award of 5,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2027. Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split. Includes restricted share units, which vest over various time periods. /s/ Matthew Wein, Attorney-in-Fact 2023-07-07